BTC $78,784.80 -1.33%
ETH $2,482.04 -1.18%
BNB $750.69 +0.32%
XRP $1.39 -1.52%
SOL $103.32 -2.13%
TRX $0.3363 -0.22%
DOGE $0.0900 -0.18%
ADA $0.2185 -0.96%
BCH $260.02 +0.52%
LINK $12.70 -4.17%
HYPE $84.32 -2.67%
AAVE $131.88 -2.86%
SUI $0.8226 +1.59%
XLM $0.1913 -0.74%
ZEC $1,136.09 -5.96%
BTC $78,784.80 -1.33%
ETH $2,482.04 -1.18%
BNB $750.69 +0.32%
XRP $1.39 -1.52%
SOL $103.32 -2.13%
TRX $0.3363 -0.22%
DOGE $0.0900 -0.18%
ADA $0.2185 -0.96%
BCH $260.02 +0.52%
LINK $12.70 -4.17%
HYPE $84.32 -2.67%
AAVE $131.88 -2.86%
SUI $0.8226 +1.59%
XLM $0.1913 -0.74%
ZEC $1,136.09 -5.96%

Quantum BioPharma Q3 Financial Report: Achieved $572,000 in Revenue through Digital Asset Portfolio

2025-11-08 08:53:05

According to GlobeNewswire, Quantum BioPharma (NASDAQ: QNTM) today announced its financial results for the third quarter of 2025, showing a significant improvement in the company's financial condition, with a 275% quarter-over-quarter increase in shareholder equity, a 50% reduction in total liabilities, and an 87% decrease in the debt-to-equity ratio.

The company's digital asset portfolio (primarily consisting of Bitcoin) has realized a gain of $572,000, with the total value of digital assets increasing from $800,000 at the end of 2024 to the current $5.2 million.

app_icon
ChainCatcher Building the Web3 world with innovations.